TY  - JOUR
AU  - Bikov, Andras
AU  - Oğuzülgen, Ipek Kivilcim
AU  - Baiardini, Ilaria
AU  - Contoli, Marco
AU  - Emelyanov, Alexander
AU  - Fassio, Omar
AU  - Ivancevich, Juan Carlos
AU  - Kaidashev, Igor
AU  - Kowal, Krzysztof
AU  - Labor, Marina
AU  - Lahousse, Lies
AU  - Mihaicuta, Stefan
AU  - Novakova, Silviya
AU  - Padilla Galo, Alicia
AU  - Simidchiev, Alexander
AU  - Tiotiu, Angelica
AU  - Ansotegui, Ignacio J
AU  - Bernstein, Jonathan A
AU  - Boulet, Louis Philippe
AU  - Canonica, Giorgio Walter
AU  - Dubuske, Lawrence
AU  - Rosario, Nelson
AU  - Santus, Pierachille
AU  - Braido, Fulvio
AU  - Interasma Scientific Network (INES)
PY  - 2020
DO  - 10.1016/j.waojou.2020.100441
SN  - 1939-4551
UR  - http://hdl.handle.net/10668/16078
T2  - The World Allergy Organization journal
AB  - Severe asthma is a serious condition with a significant burden on patients' morbidity, mortality, and quality of life. Some biological therapies targeting the IgE and interleukin-5 (IL5) mediated pathways are now available. Due to the lack of direct...
LA  - en
KW  - Behavior
KW  - Belief
KW  - Biological drug
KW  - Eos: Eosinophil, IL5
KW  - ICS, inhaled corticosteroids
KW  - INterasma Scientific Network, LABA
KW  - Immunoglobulin E, INESNET
KW  - Omalizumab. OMA/IL5, Omalizumab plus anti-IL5 molecule
KW  - Severe asthma
KW  - interleukine 5, IgE
KW  - long-acting beta2-agonist, OMA
TI  - Beliefs and preferences regarding biological treatments for severe asthma.
TY  - research article
VL  - 13
ER  -